Les films peuvent-ils influencer les choix de traitement ?
Oui, ils peuvent façonner les perceptions et les attentes des patients concernant les traitements.
Choix de traitementInfluence médiatiqueCinéma
#3
Quels films traitent des traitements innovants ?
Des films comme 'The Imitation Game' abordent des traitements innovants en médecine.
Traitements innovantsCinémaMédecine
#4
Les films montrent-ils des traitements alternatifs ?
Oui, certains films explorent des traitements alternatifs, souvent avec un regard critique.
Traitements alternatifsCinémaCritique sociale
#5
Comment les films abordent-ils l'éthique des traitements ?
Ils soulèvent souvent des questions éthiques autour des traitements médicaux et des choix des patients.
Éthique médicaleTraitementsCinéma
Complications
5
#1
Les films montrent-ils les complications des maladies ?
Oui, ils illustrent souvent les complications pour dramatiser l'impact des maladies.
ComplicationsMaladiesCinéma
#2
Comment les films traitent-ils des complications psychologiques ?
Ils explorent souvent les complications psychologiques à travers des personnages en détresse.
Complications psychologiquesCinémaSanté mentale
#3
Quels films abordent les complications des traitements ?
Des films comme 'The Constant Gardener' traitent des complications liées aux traitements médicaux.
ComplicationsTraitementsCinéma
#4
Les films peuvent-ils sensibiliser aux complications des maladies ?
Oui, ils peuvent sensibiliser le public aux complications souvent méconnues des maladies.
SensibilisationComplicationsMaladies
#5
Comment les films montrent-ils les conséquences des complications ?
Ils illustrent souvent les conséquences tragiques des complications à travers des récits poignants.
ConséquencesComplicationsCinéma
Facteurs de risque
5
#1
Les films abordent-ils les facteurs de risque des maladies ?
Oui, ils peuvent explorer les facteurs de risque à travers des récits de vie des personnages.
Facteurs de risqueMaladiesCinéma
#2
Quels films traitent des facteurs de risque liés au mode de vie ?
Des films comme 'Super Size Me' examinent les facteurs de risque liés à l'alimentation.
Mode de vieFacteurs de risqueCinéma
#3
Comment les films montrent-ils l'impact des facteurs de risque ?
Ils illustrent souvent comment les choix de vie peuvent mener à des maladies graves.
ImpactFacteurs de risqueCinéma
#4
Les films peuvent-ils sensibiliser aux facteurs de risque ?
Oui, ils peuvent éduquer le public sur les facteurs de risque souvent négligés.
SensibilisationFacteurs de risqueCinéma
#5
Comment les films traitent-ils des facteurs de risque environnementaux ?
Ils explorent souvent les impacts environnementaux sur la santé à travers des récits dramatiques.
Facteurs de risque environnementauxSantéCinéma
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Films : Questions médicales les plus fréquentes",
"headline": "Films : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Films : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-24",
"dateModified": "2025-03-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Films"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Supports audiovisuels",
"url": "https://questionsmedicales.fr/mesh/D001296",
"about": {
"@type": "MedicalCondition",
"name": "Supports audiovisuels",
"code": {
"@type": "MedicalCode",
"code": "D001296",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01.462.500.820.090"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Films",
"alternateName": "Motion Pictures",
"code": {
"@type": "MedicalCode",
"code": "D009040",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tomoyoshi Inoue",
"url": "https://questionsmedicales.fr/author/Tomoyoshi%20Inoue",
"affiliation": {
"@type": "Organization",
"name": "Department of Electronics, Graduate School of Science and Technology, Kyoto Institute of Technology, Matsugasaki Goshokaido-cho, Sakyo-ku, Kyoto, 606-8585, Japan."
}
},
{
"@type": "Person",
"name": "Kenzo Nishio",
"url": "https://questionsmedicales.fr/author/Kenzo%20Nishio",
"affiliation": {
"@type": "Organization",
"name": "Advanced Technology Center, Kyoto Institute of Technology, Matsugasaki Goshokaido-cho, Sakyo-ku, Kyoto, 606-8585, Japan."
}
},
{
"@type": "Person",
"name": "Yasuhiro Awatsuji",
"url": "https://questionsmedicales.fr/author/Yasuhiro%20Awatsuji",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Electrical Engineering and Electronics, Kyoto Institute of Technology, Matsugasaki Goshokaido-cho, Sakyo-ku, Kyoto, 606-8585, Japan. awatsuji@kit.ac.jp."
}
},
{
"@type": "Person",
"name": "Toshihiro Kubota",
"url": "https://questionsmedicales.fr/author/Toshihiro%20Kubota",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Dae Yeol Lee",
"url": "https://questionsmedicales.fr/author/Dae%20Yeol%20Lee",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Electronic Nicotine Delivery Systems and Cardiovascular/Cardiometabolic Health.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37104558",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/CIRCRESAHA.123.321565"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smoking reduction using an electronic nicotine delivery system (ENDS) with nicotine delivery similar to combustible cigarettes.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39075535",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12954-024-01064-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smoking reduction using electronic nicotine delivery systems in combination with nicotine skin patches.",
"datePublished": "2023-07-17",
"url": "https://questionsmedicales.fr/article/37458789",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00213-023-06401-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using varenicline in combination with electronic nicotine delivery systems (ENDS).",
"datePublished": "2023-08-07",
"url": "https://questionsmedicales.fr/article/37611481",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.drugalcdep.2023.110916"
}
},
{
"@type": "ScholarlyArticle",
"name": "Electronic nicotine delivery systems (ENDS): A convenient means of smoking?",
"datePublished": "2023-08-25",
"url": "https://questionsmedicales.fr/article/37634554",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.phrs.2023.106885"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Sciences de l'information",
"item": "https://questionsmedicales.fr/mesh/D007254"
},
{
"@type": "ListItem",
"position": 3,
"name": "Sources d'information",
"item": "https://questionsmedicales.fr/mesh/D000093983"
},
{
"@type": "ListItem",
"position": 4,
"name": "Moyens de communication",
"item": "https://questionsmedicales.fr/mesh/D003146"
},
{
"@type": "ListItem",
"position": 5,
"name": "Matériel d'enseignement",
"item": "https://questionsmedicales.fr/mesh/D013664"
},
{
"@type": "ListItem",
"position": 6,
"name": "Supports audiovisuels",
"item": "https://questionsmedicales.fr/mesh/D001296"
},
{
"@type": "ListItem",
"position": 7,
"name": "Films",
"item": "https://questionsmedicales.fr/mesh/D009040"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Films - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Films",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Films",
"description": "Comment les films représentent-ils le diagnostic médical ?\nLes films peuvent-ils influencer le diagnostic des patients ?\nQuels films traitent du diagnostic de maladies mentales ?\nLes films montrent-ils des erreurs de diagnostic ?\nComment les films abordent-ils le diagnostic précoce ?",
"url": "https://questionsmedicales.fr/mesh/D009040?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Films",
"description": "Comment les films illustrent-ils les symptômes d'une maladie ?\nLes films peuvent-ils exagérer les symptômes ?\nQuels films montrent des symptômes de maladies chroniques ?\nLes films influencent-ils la reconnaissance des symptômes ?\nComment les films traitent-ils des symptômes psychologiques ?",
"url": "https://questionsmedicales.fr/mesh/D009040?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Films",
"description": "Les films sensibilisent-ils à la prévention des maladies ?\nQuels films traitent de la prévention des maladies ?\nComment les films montrent-ils l'importance de la prévention ?\nLes films peuvent-ils changer les comportements préventifs ?\nComment les films abordent-ils la prévention des addictions ?",
"url": "https://questionsmedicales.fr/mesh/D009040?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Films",
"description": "Comment les films représentent-ils les traitements médicaux ?\nLes films peuvent-ils influencer les choix de traitement ?\nQuels films traitent des traitements innovants ?\nLes films montrent-ils des traitements alternatifs ?\nComment les films abordent-ils l'éthique des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D009040?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Films",
"description": "Les films montrent-ils les complications des maladies ?\nComment les films traitent-ils des complications psychologiques ?\nQuels films abordent les complications des traitements ?\nLes films peuvent-ils sensibiliser aux complications des maladies ?\nComment les films montrent-ils les conséquences des complications ?",
"url": "https://questionsmedicales.fr/mesh/D009040?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Films",
"description": "Les films abordent-ils les facteurs de risque des maladies ?\nQuels films traitent des facteurs de risque liés au mode de vie ?\nComment les films montrent-ils l'impact des facteurs de risque ?\nLes films peuvent-ils sensibiliser aux facteurs de risque ?\nComment les films traitent-ils des facteurs de risque environnementaux ?",
"url": "https://questionsmedicales.fr/mesh/D009040?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les films représentent-ils le diagnostic médical ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les films montrent souvent des diagnostics dramatiques, parfois exagérés pour l'effet narratif."
}
},
{
"@type": "Question",
"name": "Les films peuvent-ils influencer le diagnostic des patients ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent créer des attentes ou des craintes qui influencent la perception des symptômes."
}
},
{
"@type": "Question",
"name": "Quels films traitent du diagnostic de maladies mentales ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des films comme 'Un homme d'exception' explorent le diagnostic de troubles mentaux."
}
},
{
"@type": "Question",
"name": "Les films montrent-ils des erreurs de diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, souvent pour créer du suspense ou souligner des enjeux éthiques en médecine."
}
},
{
"@type": "Question",
"name": "Comment les films abordent-ils le diagnostic précoce ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils mettent en avant l'importance du diagnostic précoce pour le traitement efficace des maladies."
}
},
{
"@type": "Question",
"name": "Comment les films illustrent-ils les symptômes d'une maladie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les films utilisent des représentations visuelles dramatiques pour illustrer les symptômes."
}
},
{
"@type": "Question",
"name": "Les films peuvent-ils exagérer les symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, souvent pour accentuer le drame ou l'impact émotionnel sur le public."
}
},
{
"@type": "Question",
"name": "Quels films montrent des symptômes de maladies chroniques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des films comme 'The Fault in Our Stars' explorent les symptômes de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Les films influencent-ils la reconnaissance des symptômes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent sensibiliser le public à des symptômes moins connus ou mal compris."
}
},
{
"@type": "Question",
"name": "Comment les films traitent-ils des symptômes psychologiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils explorent souvent les symptômes psychologiques à travers des récits émotionnels complexes."
}
},
{
"@type": "Question",
"name": "Les films sensibilisent-ils à la prévention des maladies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux films intègrent des messages de prévention pour sensibiliser le public."
}
},
{
"@type": "Question",
"name": "Quels films traitent de la prévention des maladies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des films comme 'Contagion' abordent la prévention des maladies infectieuses."
}
},
{
"@type": "Question",
"name": "Comment les films montrent-ils l'importance de la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils illustrent souvent les conséquences de l'absence de prévention à travers des récits tragiques."
}
},
{
"@type": "Question",
"name": "Les films peuvent-ils changer les comportements préventifs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent encourager des comportements préventifs par des récits inspirants."
}
},
{
"@type": "Question",
"name": "Comment les films abordent-ils la prévention des addictions ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils explorent souvent les dangers des addictions et les stratégies de prévention à travers des histoires."
}
},
{
"@type": "Question",
"name": "Comment les films représentent-ils les traitements médicaux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les films montrent souvent des traitements de manière dramatique, parfois irréaliste."
}
},
{
"@type": "Question",
"name": "Les films peuvent-ils influencer les choix de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent façonner les perceptions et les attentes des patients concernant les traitements."
}
},
{
"@type": "Question",
"name": "Quels films traitent des traitements innovants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des films comme 'The Imitation Game' abordent des traitements innovants en médecine."
}
},
{
"@type": "Question",
"name": "Les films montrent-ils des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains films explorent des traitements alternatifs, souvent avec un regard critique."
}
},
{
"@type": "Question",
"name": "Comment les films abordent-ils l'éthique des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils soulèvent souvent des questions éthiques autour des traitements médicaux et des choix des patients."
}
},
{
"@type": "Question",
"name": "Les films montrent-ils les complications des maladies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils illustrent souvent les complications pour dramatiser l'impact des maladies."
}
},
{
"@type": "Question",
"name": "Comment les films traitent-ils des complications psychologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils explorent souvent les complications psychologiques à travers des personnages en détresse."
}
},
{
"@type": "Question",
"name": "Quels films abordent les complications des traitements ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des films comme 'The Constant Gardener' traitent des complications liées aux traitements médicaux."
}
},
{
"@type": "Question",
"name": "Les films peuvent-ils sensibiliser aux complications des maladies ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent sensibiliser le public aux complications souvent méconnues des maladies."
}
},
{
"@type": "Question",
"name": "Comment les films montrent-ils les conséquences des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils illustrent souvent les conséquences tragiques des complications à travers des récits poignants."
}
},
{
"@type": "Question",
"name": "Les films abordent-ils les facteurs de risque des maladies ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent explorer les facteurs de risque à travers des récits de vie des personnages."
}
},
{
"@type": "Question",
"name": "Quels films traitent des facteurs de risque liés au mode de vie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des films comme 'Super Size Me' examinent les facteurs de risque liés à l'alimentation."
}
},
{
"@type": "Question",
"name": "Comment les films montrent-ils l'impact des facteurs de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils illustrent souvent comment les choix de vie peuvent mener à des maladies graves."
}
},
{
"@type": "Question",
"name": "Les films peuvent-ils sensibiliser aux facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent éduquer le public sur les facteurs de risque souvent négligés."
}
},
{
"@type": "Question",
"name": "Comment les films traitent-ils des facteurs de risque environnementaux ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils explorent souvent les impacts environnementaux sur la santé à travers des récits dramatiques."
}
}
]
}
]
}
Department of Electronics, Graduate School of Science and Technology, Kyoto Institute of Technology, Matsugasaki Goshokaido-cho, Sakyo-ku, Kyoto, 606-8585, Japan.
Faculty of Electrical Engineering and Electronics, Kyoto Institute of Technology, Matsugasaki Goshokaido-cho, Sakyo-ku, Kyoto, 606-8585, Japan. awatsuji@kit.ac.jp.
Swiss Epilepsy Centre, Zurich, Switzerland; University of Zurich, Zurich, Switzerland; Center for Neuroscience Zurich, Zurich, Switzerland. Electronic address: h.jokeit@swissepi.ch.
Department of Animal Radiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Department of Animal Radiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Department of Animal Radiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Department of Animal Radiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan. Electronic address: amurata@mail.ecc.u-tokyo.ac.jp.
Division of Ethics in Medicine, Department of Health Services Research, University of Oldenburg, Ammerländer Heerstr. 114-118, 26129, Oldenburg, Germany. mark.schweda@uni-oldenburg.de.
About the Author Debra R. Hanna, PhD, RN, ACNS-BC, is a professor, Barbara H. Hagan School of Nursing, Molloy College, Rockville Centre, New York. For more information, contact her at dhanna@molloy.edu.
Department of Electronics, Graduate School of Science and Technology, Kyoto Institute of Technology, Matsugasaki Goshokaido-cho, Sakyo-ku, Kyoto, 606-8585, Japan.
Department of Electronics, Graduate School of Science and Technology, Kyoto Institute of Technology, Matsugasaki Goshokaido-cho, Sakyo-ku, Kyoto, 606-8585, Japan.
The use of electronic nicotine delivery systems, specifically electronic cigarettes (e-cig), has risen dramatically within the last few years; the demographic purchasing these devices is now predomina...
Electronic nicotine delivery systems (ENDS) offer a promising approach to tobacco harm reduction, but many people use both ENDS and combustible cigarettes ("dual use"), which undermines potential risk...
Twenty-five cigarette smoking adults, not seeking smoking cessation treatment, but open to using ENDS as a cigarette substitute, were provided with a 12-week supply of BIDI...
Over 12 weeks, ENDS use increased to an average of 15.8 occasions per day (SD = 20.2) and self-reported cigarette consumption decreased by 82% from 16.7 cigarettes/day (SD = 6.0) at baseline to 3.0 ci...
In this study, the ENDS effectively replicated the subjective rewarding effects of participants' usual brands of cigarettes and led to a substantial reduction in reported cigarettes/day. Exhaled CO sh...
ClinicalTrials.gov identifier NCT05855343....
Electronic nicotine delivery systems (ENDS) are used by smokers seeking to reduce combustible cigarette (CC) use, but the role of nicotine replacement vs. behavioral and sensory factors is still poorl...
To assess the effects on smoking behavior of using nicotine vs. placebo ENDS in smokers using nicotine vs. placebo patches....
Ninety-four daily smokers were enrolled in a study that randomly assigned them to receive ENDS with nicotine vs. without nicotine and skin patches with vs. without nicotine. Smoking reduction and cess...
The use of nicotine in ENDS led to significant reductions in smoking (ENDS nicotine vs. placebo difference in CO change = -9.2 ppm; 90% CI (-1.5 ppm, -16.9 ppm)) and was highly correlated with reducti...
The presence of nicotine in ENDS was associated with a large reduction in smoking. Additional studies will be needed to determine whether there may be additive effects of nicotine ENDS and nicotine pa...
Varenicline is efficacious for smoking cessation, but a return to smokingusually occurs after treatment ends. Electronic nicotine delivery systems (ENDS) may enhance smoking reduction and cessation by...
Twenty-five individuals who smoked cigarettes, interested in switching but not seeking cessation treatment, received ENDS for 13 weeks; during weeks 2-13 they received varenicline. Assessments include...
Cigarette smoking decreased from 15.6 cigarettes/day (SD=5.6) at baseline to 2.8 cigarettes/day (SD=5.1) at week 13 (paired t(22)=10.24, p<0.0001). 28% of participants were confirmed to be abstinent i...
ENDS in combination with varenicline shows promise as a means to reduce dependence on cigarettes and facilitate switching from cigarettes to ENDS....
Electronic nicotine delivery systems (ENDS), which are becoming increasingly popular in many parts of the world, have recently become more sophisticated in terms of their more active content and bette...
Although over half of United States states have passed taxes on electronic nicotine delivery systems (ENDS), recent evidence links ENDS tax rates to increases in smoking, suggesting potentially substa...
Observational study of data from the Current Population Survey's 2010-2019 Tobacco Use Supplements....
The United States....
A total of 38 906 18 to 25 year-olds MEASUREMENTS: Multivariable linear regressions estimated two-way fixed effects analyses to assess ENDS and cigarette tax rates' relationships to recent and daily s...
A $1 increase in ENDS taxes yielded significant reductions in young adults' daily vaping (...
In the United States, higher ENDS tax rates are associated with decreased ENDS use but increased cigarette smoking among 18- to 25-year-olds, with associations reversed for cigarette taxes....
To identify, characterise and broadly synthesise factors associated with child and adolescent electronic nicotine delivery systems (ENDS) and/or electronic non-nicotine delivery systems (ENNDS) ever-u...
Four electronic databases were searched from inception to 3rd June 2022. Non-experimental studies that provided quantitative factors associated with adolescent and/or child ENDS or ENNDS ever-use and/...
The search of electronic databases identified 4756 records, 240 of which were included. The majority of studies examined factors categorised within the Biology and Personality domain of the Theory of ...
The evidence base on factors associated with ENDS/ENNDS use in children and adolescents is rapidly developing, predominately by research concentrated in high income regions and focused on behavioural-...
Responsiveness to drug-related cues assesses drug reward in research studies. There are currently no validated visual image cues related to electronic nicotine delivery systems (ENDS), thus, this stud...
ENDS users and non-vaping individuals in the United States and Canada were recruited via Amazon MTurk. A total of 120 ENDS-related images and 56 neutral images, matched for visual similarity, were ass...
After excluding patterned responses, the data from 926 participants (610 ENDS users, and 316 non-vaping controls) were analyzed. When viewing ENDS-related images, desire-to-vape scores were correlated...
Correlational findings of the affective ENDS-related images were similar to those of previous studies validating collections of tobacco and alcohol picture cues, supporting the future use of these sti...
The prevalence of electronic nicotine delivery systems (ENDS) use among US youths has increased significantly during the past decade. Identifying key factors highly associated with ENDS use is essenti...
To identify the most important risk factors in wave 4.5 (ie, December 2017 to December 2018) of the Population Assessment of Tobacco and Health Study (PATH) data that are associated with ENDS use in w...
This prognostic study examined data from waves 4.5 and 5 of the PATH youth data set using machine learning techniques. The PATH study is a nationally representative longitudinal cohort study of tobacc...
Wave 5 current ENDS use status of wave 4.5 adolescents who were tobacco-naive....
The analyzed data set comprised 7943 individuals who were tobacco-naive in wave 4.5. Among this group, 332 participants (4.2%) indicated their present use of ENDS in wave 5, 5047 (63.5%) were aged 12 ...
The findings of this study suggest that family and friends play an important role in ENDS use among adolescents. The top-ranking factors associated with ENDS use in this study are areas for further ex...
The combination of electronic nicotine delivery systems (ENDS) device and liquid characteristics affect user nicotine and toxicant exposure, however population-level national survey studies have not r...
U.S. adults (21+) using ENDS at least five days/week (n = 1,179) completed an online survey in 2020 and uploaded photos of their most used device and liquid. Device/liquid combinations were analyzed t...
Five device/liquid combinations accounted for 87 % of those reported. The most prevalent combination, reported by 36.2 %, was re-useable devices with adjustable settings and a tank refilled with a fre...
Analyzing ENDS device/liquid combinations rather than each separately can allow researchers to better evaluate relationships between use and key outcomes, such as quitting cigarettes and abuse liabili...
